The relationship of serum inflammatory markers with metabolic disorders at the non-alcoholic fatty liver disease
Journal Title: Сучасна гастроентерологія - Year 2018, Vol 0, Issue 5
Abstract
Objective — to study the serum levels of proinflammatory markers and determine their role in the formation of metabolic disorders in patients with non-alcoholic fatty liver disease (NAFLD). Materials and methods. Examinations involved 92 patients with NAFLD, 48 of them were diagnosed with non-alcoholic steatosis (NAS) and 44 patients with non-alcoholic steatohepatitis (NASH). The mean age of the examined patients was NAFLD was (58.44 ± 11.8) years; the gender distribution was reciprocal. The control group consisted of 30 practically healthy persons. The parameters of objective and instrumental examinations were determined in all patients in accordance with the current order of the Ministry of Health of Ukraine No. 826 dated November 6, 2014. In addition to the standard survey, the OMRON BF-511 electronic device was monitored by the patient’s body composition (Japan, 2011). For the determination of visceral fat tissue dysfunction (VFT), the index of visceral obesity (IVO) was calculated by the M. C. Amato method (2010). Determination of levels of C-reactive protein (CRP) and tumour necrosis factor (FNP)-alpha in serum was performed by the immune enzyme method. Results. CRP was significantly increased in the group of patients with NASH compared to the controls (p < 0.05), while significant differences in patients in the NAS group were not detected. Determination of the concentration of TNF-alpha in the blood serum of the examined patients showed a significant increase in both the NAS group and the NASH group compared with the control group (p < 0.05). There was a direct correlation between the level of TNF-alpha and the activity of cytolytic enzymes (ALT and gamma-GGT), triglyceride levels, as well as insulin on an empty stomach and the HOMA-index. The dependence of ALT activity on the level of CRP (r = 0.35; p = 0.032) was established. It was established that as the activity of VFT increased, an increase in serum concentrations of both TNF and CRP was observed. Conclusions. The most significant increase in CRP and TNF-α and VFT rates was observed in patients with NASH. An elevated level of TNF-alpha promoted the development of inflammation in the liver in patients with signs of a metabolic syndrome and can be considered as a risk factor for the development of NASH in patients with NAFLD.
Authors and Affiliations
G. D. Fadieienko, I. E. Kushnir, V. M. Chernova, T. A. Solomenseva, O. G. Kurinna, Ya. V. Nikiforova, V. Yu. Galchinska, I. V. Shute, O. Ye. Gridniev
Deep cystic gastritis: literature review and clinical case
The article presents the overview of recent literature data on a rare variant of chronic gastritis, deep cystic gastritis (gastritis cysticaprofunda). In the most cases, this disease is diagnosed histologically in patien...
The role of intestinal microbiota in the development of metabolic disorders
It is known that ahuman intestine contains more than 100 trillion microbial cells, which play an important role in the regulation of human metabolism through their symbiotic interactions with the host. The modified intes...
The restoration of stomach mucosa in patients with chronic erosive Helicobacter pylori-associated gastritis
Objective — to investigate efficacy of preparation of pro-vitamin B5 and vitamin U in the complex therapy of patients with chronic erosive gastritis, associated with H. pylori, combined with the pancreas excretory insuff...
Dermatological paraneoplastic syndromes in gastroenterology: prediction of the inevitable or guidance to action? Part I
This article presents information on paraneoplastic syndromes (PNS) — various pathologies and conditions that accompany and sometimes precede the onset of malignant visceral neoplasms. Although some of the PNS and neopla...
Sate of intestinal microbiome in patients with osteoarthritis
Objective — to study the composition of intestinal microflora (CM) in patients with osteoarthritis (OA) against the background of administration of non-steroidal anti-inflammatory drugs (NSAIDs) and without them, as well...